In an interview to CNBC-TV18, Pravin Herlekar, CMD of Omkar Speciality Chemicals discussed the company's Q1 performance.

Omkar Speciality Chemicals to expand business operations

The company said it would further like to penetrate into segments like fragrances and flavours, food and beverages, etc. in which new products will be launched in the immediate future.

Omkar Speciality gets patent for beta ketoester chemical process

Pravin Herlekar, Chairman and Managing Director of the company told CNBC-TV18 that the patent, fourth one for the firm, is for beta ketoester chemical. There are seven more patents in the pipeline, he added.

Margins can sustain at current levels: Omkar Speciality

A diversified product and customer portfolio leading to lower dependence on any particular product or customer gives Omkar Speciality the confidence of sustaining healthy margins, says Chairman and Managing Director Pravin Herlekar.

Targeting 80% capacity utilisation in FY17: Omkar Specialty

With capacity utilisation enhancement measures, Omkar Specialty Chemicals expects to clock in revenues of Rs 430 crore going ahead.

Expect FY17 topline to grow 20% on back of new drug: Omkar

Omkar Speciality Chemicals' whole time director Omkar P Herlekar is confident of logging a growth rate above industry standards for FY16.

Omkar Speciality Chemicals eyes 20-25% rev growth in FY15

Speciality chemicals manufacturer eyes revenue growth of 20-25 percent in FY15, says CMD Pravin Herlekar, adding that the company will maintain profit after tax (PAT) margins of 7-8 percent in this fiscal, which will improve in FY16.

Omkar Speciality has growth plans for new purchase LASA Lab

Pravin Herlekar, the chairman and managing director of Omkar Speciality Chemicals says LASA Lab is an attractive buy for the company as it is an established player in the API segment.

Omkar Speciality to expand capacity to 3650 metric tonne

In an interview with CNBC-TV18, Pravin Shivdas Harlekar, MD, Omkar Speciality said the company’s existing capacity is 950 metric tonne. “By FY13, we would like to expand up to 3,650 metric tonne per year,” he added.

Expect top-line to grow at 50-55% in FY12: Omkar Speciality

Omkar Speciality Chemicals saw a strong profit growth in FY11. Speaking exclusively to CNBC-TV18, the company’s managing director Pravin Shivdas Harlekar says that the company that manufactures specialty chemicals is likely to “maintain the trend.”

Omkar Speciality targets 45% revenue growth in FY12

In an interview with CNBC-TV18, Pravin Shivdas Harlekar, MD, Omkar Speciality says, the company is targeting atleast 45% revenue growth in FY12.

Expect 45% growth in FY11: Omkar Speciality

In an exclusive interview with CNBC-TV18’s Soniya Shenoy and Ekta Batra, Pravin Shivdas Harlekar, Chairman and Managing Director of Omkar Speciality says that the company is confident of a 45% growth in revenues in FY11. “The target is to cross Rs 150 crore in 2011-12,” he says.